Discover the latest breakthroughs, partnerships, and insights from PepKon. Innovation moves fast—don’t miss a beat.
PepKon is proud to be a semi-finalist in the EIT Catapult program, joining the top 30 European start-ups. This recognition underscores PepKon’s innovation in oncology and supports its growth with visibility and resources. This milestone reinforces PepKon’s commitment to advancing peptide therapies and moving towards clinical development.
PepKon is pleased to announce its participation at BIO-Europe in Stockholm from November 3-5. This major event brings together key players in the biotech and pharmaceutical industries, offering unique opportunities for networking, partnerships, and showcasing innovative research.
